IL135993A0 - Pharmaceutical composition for the treatment of fibrosis - Google Patents

Pharmaceutical composition for the treatment of fibrosis

Info

Publication number
IL135993A0
IL135993A0 IL13599300A IL13599300A IL135993A0 IL 135993 A0 IL135993 A0 IL 135993A0 IL 13599300 A IL13599300 A IL 13599300A IL 13599300 A IL13599300 A IL 13599300A IL 135993 A0 IL135993 A0 IL 135993A0
Authority
IL
Israel
Prior art keywords
fibrosis
treatment
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
IL13599300A
Other languages
English (en)
Original Assignee
Omrix Biopharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omrix Biopharmaceuticals filed Critical Omrix Biopharmaceuticals
Priority to IL13599300A priority Critical patent/IL135993A0/xx
Priority to US09/846,325 priority patent/US20010038840A1/en
Priority to EP01110887A priority patent/EP1153611A3/de
Publication of IL135993A0 publication Critical patent/IL135993A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39516—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from serum, plasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Surgery (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Vascular Medicine (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL13599300A 2000-05-05 2000-05-05 Pharmaceutical composition for the treatment of fibrosis IL135993A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IL13599300A IL135993A0 (en) 2000-05-05 2000-05-05 Pharmaceutical composition for the treatment of fibrosis
US09/846,325 US20010038840A1 (en) 2000-05-05 2001-05-02 Method for the treatment of fibrosis
EP01110887A EP1153611A3 (de) 2000-05-05 2001-05-04 Pharmazeutische Zusammensetzung zur Behandlung von Fibrose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL13599300A IL135993A0 (en) 2000-05-05 2000-05-05 Pharmaceutical composition for the treatment of fibrosis

Publications (1)

Publication Number Publication Date
IL135993A0 true IL135993A0 (en) 2001-05-20

Family

ID=11074104

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13599300A IL135993A0 (en) 2000-05-05 2000-05-05 Pharmaceutical composition for the treatment of fibrosis

Country Status (3)

Country Link
US (1) US20010038840A1 (de)
EP (1) EP1153611A3 (de)
IL (1) IL135993A0 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005232436C1 (en) * 2004-04-15 2010-08-26 Athera Biotechnologies Ab Annexin V for preventing atherothrombosis and plaque rupture
WO2010132686A1 (en) * 2009-05-13 2010-11-18 Gliknik, Inc. Methods of using immunoglobulin aggregates
FR2952826B1 (fr) 2009-11-20 2012-04-06 Lab Francais Du Fractionnement Utilisation d'immunoglobulines polyvalentes pour traiter une cirrhose hepatique alcoolique ou metabolique

Also Published As

Publication number Publication date
EP1153611A2 (de) 2001-11-14
EP1153611A3 (de) 2002-01-30
US20010038840A1 (en) 2001-11-08

Similar Documents

Publication Publication Date Title
EG24357A (en) New Pharmaceutical composition
IL152659A0 (en) Pharmaceutical composition
HK1075889A1 (en) Pharmaceutical composition
IL196301A0 (en) Medicament for the treatment of hapatitis c
HUP0204137A3 (en) Pharmaceutical composition comprising fulvestrant
PL351387A1 (en) Pharmaceutical composition
HUP0301325A3 (en) Stabilized pharmaceutically effective composition and pharmaceutical composition comprising the same and process for preparation the composition
HUP0204555A3 (en) Pharmaceutical composition
EP1450824A4 (de) Pharmazeutische zusammensetzung
HUP0203311A3 (en) New pharmaceutical compositions of prolonged effect
GB0002386D0 (en) Therapeutic composition
EP1408896A4 (de) Pharmazeutische zusammensetzung
IL154238A0 (en) Pharmaceutical composition
IL137275A0 (en) Pharmaceutical composition for the treatment of anal fissures
IL135993A0 (en) Pharmaceutical composition for the treatment of fibrosis
GB0005382D0 (en) Pharmaceutical composition
AU5416500A (en) Pharmaceutical composition for the treatment of calcification
IL136687A0 (en) Pharmaceutical composition for the treatment of multiple sclerosis
HU0003973D0 (en) Pharmaceutical composition for the treatment of aids
GB0101094D0 (en) Pharmaceutical composition
GB0002691D0 (en) Pharmaceutical composition
GB0021927D0 (en) Use of pharmaceutical combination
GB0006301D0 (en) Pharmaceutical composition
GB0027375D0 (en) Pharmaceutical composition
GB0016684D0 (en) Pharmaceutical composition